Colorado Springs Health Partners- East/Clinical Research Advantage — Colorado Springs, Colorado

Colorado Springs Health Partners- East/Clinical Research Advantage is a clinical research site located in Colorado Springs, Colorado, United States 80922.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Colorado Springs Health Partners- East/Clinical Research Advantage has participated in 1 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Colorado Springs

Browse all research sites in Colorado · View every site in Colorado Springs

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Springs Health Partners- East/Clinical Research Advantage?

Colorado Springs Health Partners- East/Clinical Research Advantage has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Springs Health Partners- East/Clinical Research Advantage conducted?

Colorado Springs Health Partners- East/Clinical Research Advantage has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.

Is Colorado Springs Health Partners- East/Clinical Research Advantage accredited by Crixeo Clinical Trials?

Colorado Springs Health Partners- East/Clinical Research Advantage has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Springs Health Partners- East/Clinical Research Advantage?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.